Lack of response in DLBCL is at least in part due to evasion of apoptosis, a hallmark of cancer, often resulting from aberrations in pro-survival BH3 proteins of the B-cell leukemia/lymphoma-2 (BCL-2) family7,8. The gene discussed is BCL2; the disease is cancer.